These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26771192)

  • 1. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.
    Basu A; Cajigas-Du Ross CK; Rios-Colon L; Mediavilla-Varela M; Daniels-Wells TR; Leoh LS; Rojas H; Banerjee H; Martinez SR; Acevedo-Martinez S; Casiano CA
    PLoS One; 2016; 11(1):e0146549. PubMed ID: 26771192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cells.
    Basu A; Drame A; Muñoz R; Gijsbers R; Debyser Z; De Leon M; Casiano CA
    Prostate; 2012 May; 72(6):597-611. PubMed ID: 21796653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75.
    Brown-Bryan TA; Leoh LS; Ganapathy V; Pacheco FJ; Mediavilla-Varela M; Filippova M; Linkhart TA; Gijsbers R; Debyser Z; Casiano CA
    Mol Cancer Res; 2008 Aug; 6(8):1293-307. PubMed ID: 18708362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity.
    Leoh LS; van Heertum B; De Rijck J; Filippova M; Rios-Colon L; Basu A; Martinez SR; Tungteakkhun SS; Filippov V; Christ F; De Leon M; Debyser Z; Casiano CA
    Mol Cancer Res; 2012 Mar; 10(3):378-91. PubMed ID: 22275515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells.
    Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
    Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
    Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis.
    Daniels T; Zhang J; Gutierrez I; Elliot ML; Yamada B; Heeb MJ; Sheets SM; Wu X; Casiano CA
    Prostate; 2005 Jan; 62(1):14-26. PubMed ID: 15389814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
    Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
    Basu A; Rojas H; Banerjee H; Cabrera IB; Perez KY; De León M; Casiano CA
    PLoS One; 2012; 7(1):e30132. PubMed ID: 22276150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
    Mediavilla-Varela M; Pacheco FJ; Almaguel F; Perez J; Sahakian E; Daniels TR; Leoh LS; Padilla A; Wall NR; Lilly MB; De Leon M; Casiano CA
    Mol Cancer; 2009 Aug; 8():68. PubMed ID: 19715609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis.
    Ganapathy V; Daniels T; Casiano CA
    Autoimmun Rev; 2003 Sep; 2(5):290-7. PubMed ID: 12965181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders.
    Wu X; Daniels T; Molinaro C; Lilly MB; Casiano CA
    Cell Death Differ; 2002 Sep; 9(9):915-25. PubMed ID: 12181742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.
    Cohen B; Addadi Y; Sapoznik S; Meir G; Kalchenko V; Harmelin A; Ben-Dor S; Neeman M
    Neoplasia; 2009 Sep; 11(9):921-33. PubMed ID: 19724686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of heavy subunit chain of gamma-glutamylcysteine synthetase by tumor necrosis factor-alpha in lens epithelial cells: role of LEDGF/p75.
    Takamura Y; Fatma N; Kubo E; Singh DP
    Am J Physiol Cell Physiol; 2006 Feb; 290(2):C554-66. PubMed ID: 16403949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter.
    Singh DP; Bhargavan B; Chhunchha B; Kubo E; Kumar A; Fatma N
    PLoS One; 2012; 7(5):e37012. PubMed ID: 22615874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
    Huang TS; Myklebust LM; Kjarland E; Gjertsen BT; Pendino F; Bruserud Ø; Døskeland SO; Lillehaug JR
    Mol Cancer; 2007 Apr; 6():31. PubMed ID: 17451600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
    Liedtke V; Rose L; Hiemann R; Nasser A; Rödiger S; Bonaventura A; Winkler L; Sowa M; Stöckle M; Schierack P; Junker K; Roggenbuck D
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEDGF/p75 TATA-less promoter is driven by the transcription factor Sp1.
    Desfarges S; Abderrahmani A; Hernàndez-Novoa B; Munoz M; Ciuffi A
    J Mol Biol; 2011 Nov; 414(2):177-93. PubMed ID: 22019592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
    Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
    J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of the ternary complex formed by c-Myc interactor JPO2, transcriptional co-activator LEDGF/p75, and chromatin.
    Hendrix J; van Heertum B; Vanstreels E; Daelemans D; De Rijck J
    J Biol Chem; 2014 May; 289(18):12494-506. PubMed ID: 24634210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.